Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis
Apoptosis · 2023-04 · 28 (3-4) · 348-361
DOI: 10.1007/s10495-022-01792-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, online erschienen am 12.11.2022. Verfasst von Mei Zi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology; School of Materials Science and Engineering, Peking University, No.…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is a malignant tumor with high mortality and poor prognosis. Many OSCC patients have low response rate to current treatments including immunotherapies largely due to the immune-suppressive tumor microenvironment (TME). Chemotherapy could induce immunogenic cell death (ICD), a type of cell death such as pyroptosis and necroptosis, which has proved to be capable to alter the immune-suppressive TME and beneficial for better anti-tumor effect. GSDME, a key protein of pyroptosis, is however often silenced in tumors due to abnormal methylation. To overcome these limitations, we utilizied methyltransferase inhibitor (decitabine, DAC) to trigger pyroptosis of tumor cells, combined with chemodrug cisplatin (DDP) and immune checkpoints inhibitors to amplify the immunotherapies outcomes. To the best of our knowledge, this is the first study of tumor suppressive effect of GSDME in OSCC. Our investigation demonstrated that stimulation of GSDME expression could improve the sensitivity of chemotherapeutics, activate inflammatory tumor cell pyroptosis and alter the tumor immune-suppressive microenvironment, providing an important perspective for clinical OSCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology; School of Materials Science and Engineering, Peking University, No.22, Zhongguancun South Avenue, Haidian District, Beijing, 100871, Peop…
- Biomedical Pioneering Innovation Center (BIOPIC)State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, 100871, People's Republic of China.
- Laboratory of Biomaterials and Regenerative Medicine, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, People's Republic of China.
- Laboratory of Biomaterials and Regenerative Medicine, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, People's Republic of China. sc-wei@pku.edu.cn.
- , No.22, Zhongguancun South Avenue, Haidian District, Beijing, 100081, People's Republic of China. sc-wei@pku.edu.cn.
ORCID-Profile: Lv Shixian
Zitieren
APA
Zi, M., Xingyu, C., Yang, C., Xiaodong, S., Shixian, L., & Shicheng, W. (2023). Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis. Apoptosis, 28(3-4), 348-361. https://doi.org/10.1007/s10495-022-01792-3
Vancouver
Zi M, Xingyu C, Yang C, Xiaodong S, Shixian L, Shicheng W. Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis. Apoptosis. 2023;28(3-4):348-361. doi:10.1007/s10495-022-01792-3
BibTeX
@article{Zi2023,
author = {Zi, Mei and Xingyu, Chen and Yang, Chen and Xiaodong, Su and Shixian, Lv and Shicheng, Wei},
title = {Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis},
journal = {Apoptosis},
year = {2023},
volume = {28},
number = {3-4},
pages = {348--361},
doi = {10.1007/s10495-022-01792-3}
}
EUVIMED